AAAAAA

   
Results: 1-25 | 26-33
Results: 1-25/33
CHARACTERISTICS OF ACUTE PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AND ASSOCIATION WITH LONG-TERM MORTALITY RISK
Authors: MOFENSON LM YOGEV R KORELITZ J BETHEL J KRASINSKI K MOYE J NUGENT R RIGAUPEREZ JG
Citation: Lm. Mofenson et al., CHARACTERISTICS OF ACUTE PNEUMONIA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN AND ASSOCIATION WITH LONG-TERM MORTALITY RISK, The Pediatric infectious disease journal, 17(10), 1998, pp. 872-880
A PRACTICE GUIDELINE FOR ASSESSMENT OF COMPETENCE AND CAPACITY OF THEOLDER ADULT
Authors: BAKER RR LICHTENBERG PA MOYE J
Citation: Rr. Baker et al., A PRACTICE GUIDELINE FOR ASSESSMENT OF COMPETENCE AND CAPACITY OF THEOLDER ADULT, Professional psychology, research and practice, 29(2), 1998, pp. 149-154
DETERMINATIONS OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - REASSESSMENT OF PARAMETERS AFFECTING ASSAY OUTCOME
Authors: LEW J REICHELDERFER P FOWLER M BREMER J CARROL R CASSOL S CHERNOFF D COOMBS R CRONIN M DICKOVER R FISCUS S HERMAN S JACKSON B KORNEGAY J KOVACS A MCINTOSH K MEYER W MICHAEL N MOFENSON L MOYE J QUINN T ROBB M VAHEY M WEISER B YEGHIAZARIAN T
Citation: J. Lew et al., DETERMINATIONS OF LEVELS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RNA IN PLASMA - REASSESSMENT OF PARAMETERS AFFECTING ASSAY OUTCOME, Journal of clinical microbiology, 36(6), 1998, pp. 1471-1479
PHASE-I SAFETY AND PHARMACOKINETICS STUDY OF MICRONIZED ATOVAQUONE INHUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN
Authors: HUGHES W DORENBAUM A YOGEV R BEAUCHAMP B XU J MCNAMARA J MOYE J PURDUE L VANDYKE R ROGERS M SADLER B
Citation: W. Hughes et al., PHASE-I SAFETY AND PHARMACOKINETICS STUDY OF MICRONIZED ATOVAQUONE INHUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN, Antimicrobial agents and chemotherapy, 42(6), 1998, pp. 1315-1318
A COMPARISON OF PERIPHERAL-BLOOD COCULTURE VERSUS 18-MONTH OR 24-MONTH SEROLOGY IN THE DIAGNOSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE OFFSPRING OF INFECTED MOTHERS
Authors: MCINTOSH K FITZGERALD G PITT J BREMER JW HILLYER GV LANDESMAN S ROSENBLATT H LEW JF DAVENNY K MOYE J
Citation: K. Mcintosh et al., A COMPARISON OF PERIPHERAL-BLOOD COCULTURE VERSUS 18-MONTH OR 24-MONTH SEROLOGY IN THE DIAGNOSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION IN THE OFFSPRING OF INFECTED MOTHERS, The Journal of infectious diseases, 178(2), 1998, pp. 560-563
CLINICAL-TRIALS OF HIVIG - REPLY
Authors: LAMBERT JS MOFENSON LM MOYE J
Citation: Js. Lambert et al., CLINICAL-TRIALS OF HIVIG - REPLY, The Journal of infectious diseases, 178(2), 1998, pp. 598-599
IMMUNE COMPLEX-DISSOCIATED P24 ANTIGEN IN CONGENITAL OR PERINATAL HIV-INFECTION - ROLE IN THE DIAGNOSIS AND ASSESSMENT OF RISK OF INFECTIONIN INFANTS
Authors: RICH KC JANDA W KALISH LA LEW J HOFHEINZ D LANDESMAN S PITT J DIAZ C MOYE J SULLIVAN JL
Citation: Kc. Rich et al., IMMUNE COMPLEX-DISSOCIATED P24 ANTIGEN IN CONGENITAL OR PERINATAL HIV-INFECTION - ROLE IN THE DIAGNOSIS AND ASSESSMENT OF RISK OF INFECTIONIN INFANTS, Journal of acquired immune deficiency syndromes and human retrovirology, 15(3), 1997, pp. 198-203
LYMPHOCYTE PHENOTYPING IN INFANTS - MATURATION OF LYMPHOCYTE SUBPOPULATIONS AND THE EFFECTS OF HIV-INFECTION
Authors: RICH KC BRAMBILLA D PITT J MOYE J COOPER E HILLYER G MENDEZ H FOWLER MG LANDAY A
Citation: Kc. Rich et al., LYMPHOCYTE PHENOTYPING IN INFANTS - MATURATION OF LYMPHOCYTE SUBPOPULATIONS AND THE EFFECTS OF HIV-INFECTION, Clinical immunology and immunopathology, 85(3), 1997, pp. 273-281
THE RELATIONSHIP BETWEEN SERUM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVEL, CD4 LYMPHOCYTE PERCENT, AND LONG-TERM MORTALITY RISK IN HIV-1-INFECTED CHILDREN
Authors: MOFENSON LM KORELITZ J MEYER WA BETHEL J RICH K PAHWA S MOYE J NUGENT R READ J
Citation: Lm. Mofenson et al., THE RELATIONSHIP BETWEEN SERUM HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) RNA LEVEL, CD4 LYMPHOCYTE PERCENT, AND LONG-TERM MORTALITY RISK IN HIV-1-INFECTED CHILDREN, The Journal of infectious diseases, 175(5), 1997, pp. 1029-1038
DEFINING THE TIME OF FETAL OR PERINATAL ACQUISITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE BASIS OF AGE AT FIRST POSITIVE CULTURE
Authors: KALISH LA PITT J LEW J LANDESMAN S DIAZ C HERSHOW R HOLLINGER FB PAGANO M SMERIGLIO V MOYE J
Citation: La. Kalish et al., DEFINING THE TIME OF FETAL OR PERINATAL ACQUISITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION ON THE BASIS OF AGE AT FIRST POSITIVE CULTURE, The Journal of infectious diseases, 175(3), 1997, pp. 712-715
SAFETY AND PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IMMUNOGLOBULIN ADMINISTERED TO HIV-INFECTED PREGNANT-WOMEN AND THEIR NEWBORNS
Authors: LAMBERT JS MOFENSON LM FLETCHER CV MOYE J STIEHM ER MEYER WA NEMO GJ MATHIESON BJ HIRSCH G SAPAN CV CUMMINS LM JIMENEZ E ONEILL E KOVACS A STEK A
Citation: Js. Lambert et al., SAFETY AND PHARMACOKINETICS OF HYPERIMMUNE ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IMMUNOGLOBULIN ADMINISTERED TO HIV-INFECTED PREGNANT-WOMEN AND THEIR NEWBORNS, The Journal of infectious diseases, 175(2), 1997, pp. 283-291
CLINICAL AND LABORATORY CHARACTERISTICS OF A LARGE COHORT OF SYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN
Authors: ENGLUND JA BAKER CJ RASKINO C MCKINNEY RE LIFSCHITZ MH PETRIE B FOWLER MG CONNOR JD MENDEZ H ODONNELL K WARA DW SHLIOZBERG J SHEARER WT STECHENBERG B BORKOWSKY W BONAFORTE RJ COOPER ER WIZNIA A TOLTZIS P ISRAELE V VANDYKE RB YOGEV R STARR S OLESKE F FRENKEL L MCINTOSH K MONTGOMERY M PETRU A SQUIRES JE WADE N MOORE EC RAKUSAN TA BAKER RC BRADY MT PILDES RS CERVIA JS WILFERT C NESHEIM S BELLANTI JA KELLER M ABRAMS EJ DOSSETT JH RANA SR TISHLER DM NICHOLAS SW LAMBERT JS WONG V GUPTA A DEVEIKIS A KOVACS A JOHNSON G BAMJI M SACKS HS PAHWA S GARCIARIAS D FLYNN C PHILIPP CS JIMENEZ E BONAGURA VR SHENAP JL GRIECO MH LISCHNER H MINNEFOR AB MALDONADO Y NACHMAN SA FIKRIG S WEINER LB LEVIN M GERSHON AA BRYSON Y SPECTOR S DIAZ C REICHMAN RR ROBINSON J LUZURIAGA K CRAIN MJ LIM W RICH K VINK PE DOYLE MG SCOTT GB MUNOZ J ANDIMAN WA BEHRMAN R HETHERINGTON S MCLAREN C MILLISON K MOYE J NOZYCE M PEARSON DA PURDUE L SCHOENFELD D SCOTT G SPECTOR SA
Citation: Ja. Englund et al., CLINICAL AND LABORATORY CHARACTERISTICS OF A LARGE COHORT OF SYMPTOMATIC, HUMAN IMMUNODEFICIENCY VIRUS-INFECTED INFANTS AND CHILDREN, The Pediatric infectious disease journal, 15(11), 1996, pp. 1025-1036
THEORETICAL FRAMEWORKS FOR COMPETENCE IN COGNITIVELY IMPAIRED ELDERLYADULTS
Authors: MOYE J
Citation: J. Moye, THEORETICAL FRAMEWORKS FOR COMPETENCE IN COGNITIVELY IMPAIRED ELDERLYADULTS, Journal of aging studies, 10(1), 1996, pp. 27-42
SAFETY AND IMMUNOGENICITY OF HIV RECOMBINANT ENVELOPE VACCINES IN HIV-INFECTED INFANTS AND CHILDREN
Authors: LAMBERT JS MCNAMARA J KATZ S LIVINGSTON R MOYE J
Citation: Js. Lambert et al., SAFETY AND IMMUNOGENICITY OF HIV RECOMBINANT ENVELOPE VACCINES IN HIV-INFECTED INFANTS AND CHILDREN, Pediatric research, 39(4), 1996, pp. 57-57
DIAGNOSIS OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY A DNA-POLYMERASE CHAIN-REACTION ASSAY AMONG INFANTS ENROLLED IN THE WOMEN AND INFANTS TRANSMISSION STUDY
Authors: BREMER JW LEW JF COOPER E HILLYER GV PITT J HANDELSMAN E BRAMBILLA D MOYE J HOFF R
Citation: Jw. Bremer et al., DIAGNOSIS OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY A DNA-POLYMERASE CHAIN-REACTION ASSAY AMONG INFANTS ENROLLED IN THE WOMEN AND INFANTS TRANSMISSION STUDY, The Journal of pediatrics, 129(2), 1996, pp. 198-207
EARLY DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS ON DRIED BLOOD SPOT SPECIMENS - SENSITIVITY ACROSS SERIAL SPECIMENS
Authors: COMEAU AM PITT J HILLYER GV LANDESMAN S BREMER J CHANG BH LEW J MOYE J GRADY GF MCINTOSH K
Citation: Am. Comeau et al., EARLY DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS ON DRIED BLOOD SPOT SPECIMENS - SENSITIVITY ACROSS SERIAL SPECIMENS, The Journal of pediatrics, 129(1), 1996, pp. 111-118
NATURAL-HISTORY OF SOMATIC GROWTH IN INFANTS BORN TO WOMEN INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: MOYE J RICH KC KALISH LA SHEON AR DIAZ C COOPER ER PITT J HANDELSMAN E
Citation: J. Moye et al., NATURAL-HISTORY OF SOMATIC GROWTH IN INFANTS BORN TO WOMEN INFECTED BY HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of pediatrics, 128(1), 1996, pp. 58-69
AFTER AIDS CLINICAL-TRIAL-076 - THE CHANGING PATTERN OF ZIDOVUDINE USE DURING PREGNANCY, AND THE SUBSEQUENT REDUCTION IN THE VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN A COHORT OF INFECTED WOMEN AND THEIR INFANTS
Authors: COOPER ER NUGENT RP DIAZ C PITT J HANSON C KALISH LA MENDEZ H ZORRILLA C HERSHOW R MOYE J SMERIGLIO V FOWLER MG RICH K TURPIN D PACHECOACOSTA E TUOMALA R MESTHENE D FOX H HIGGINS A LANDESMAN S MOROSO G WILLOUGHBY A SHEON A MCKINLAY S SHERRIEB K
Citation: Er. Cooper et al., AFTER AIDS CLINICAL-TRIAL-076 - THE CHANGING PATTERN OF ZIDOVUDINE USE DURING PREGNANCY, AND THE SUBSEQUENT REDUCTION IN THE VERTICAL TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN A COHORT OF INFECTED WOMEN AND THEIR INFANTS, The Journal of infectious diseases, 174(6), 1996, pp. 1207-1211
INTERLABORATORY VARIABILITY OF CD8 SUBSET MEASUREMENTS BY FLOW-CYTOMETRY AND ITS APPLICATIONS TO MULTICENTER CLINICAL-TRIALS
Authors: LANDAY AL BRAMBILLA D PITT J HILLYER G GOLENBOCK D MOYE J LANDESMAN S KAGAN J TUOMALA R FOX H MENDEZ H DIAZ C RICH K MCKINLAY S MESTHENE D HIGGINS A PACHECOACOSTA E ALEXANDER G FOWLER MG SHEON AR STRATTON P
Citation: Al. Landay et al., INTERLABORATORY VARIABILITY OF CD8 SUBSET MEASUREMENTS BY FLOW-CYTOMETRY AND ITS APPLICATIONS TO MULTICENTER CLINICAL-TRIALS, Clinical and diagnostic laboratory immunology, 2(4), 1995, pp. 462-468
SINUSITIS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - CLINICAL CHARACTERISTICS, RISK-FACTORS, AND PROPHYLAXIS
Authors: MOFENSON LM KORELITZ J PELTON S MOYE J NUGENT R BETHEL J
Citation: Lm. Mofenson et al., SINUSITIS IN CHILDREN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - CLINICAL CHARACTERISTICS, RISK-FACTORS, AND PROPHYLAXIS, Clinical infectious diseases, 21(5), 1995, pp. 1175-1181
POSTDOCTORAL TRAINING IN GEROPSYCHOLOGY - GUIDELINES FOR FORMAL PROGRAMS AND CONTINUING-EDUCATION
Authors: MOYE J BROWN E
Citation: J. Moye et E. Brown, POSTDOCTORAL TRAINING IN GEROPSYCHOLOGY - GUIDELINES FOR FORMAL PROGRAMS AND CONTINUING-EDUCATION, Professional psychology, research and practice, 26(6), 1995, pp. 591-597
PHARMACOKINETICS OF P24 ANTIBODY (AB) IN HIV-CIRCLE-PLUS PREGNANT FEMALE AND NEWBORNS RECEIVING HYPERIMMUNE HIV IMMUNOGLOBULIN (HIVIG) IN ACTG PROTOCOL 185
Authors: MOFENSON L LAMBERT J FLETCHER C STIEHM ER MOYE J MEYER W NEMO G MATHIESON B HIRSCH G
Citation: L. Mofenson et al., PHARMACOKINETICS OF P24 ANTIBODY (AB) IN HIV-CIRCLE-PLUS PREGNANT FEMALE AND NEWBORNS RECEIVING HYPERIMMUNE HIV IMMUNOGLOBULIN (HIVIG) IN ACTG PROTOCOL 185, Journal of cellular biochemistry, 1995, pp. 240-240
TRANSFER TRAUMA - WHAT CAN PATIENTS TELL US
Authors: WILLIAMS CL MOYE J DOMINGOS K BEAL L PALS JK PITTMAN R MINAKER KL
Citation: Cl. Williams et al., TRANSFER TRAUMA - WHAT CAN PATIENTS TELL US, Journal of the American Geriatrics Society, 43(9), 1995, pp. 57-57
CROSSOVER OF PLACEBO PATIENTS TO INTRAVENOUS IMMUNOGLOBULIN CONFIRMS EFFICACY FOR PROPHYLAXIS OF BACTERIAL-INFECTIONS AND REDUCTION OF HOSPITALIZATIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN
Authors: MOFENSON LM MOYE J KORELITZ J BETHEL J HIRSCHHORN R NUGENT R
Citation: Lm. Mofenson et al., CROSSOVER OF PLACEBO PATIENTS TO INTRAVENOUS IMMUNOGLOBULIN CONFIRMS EFFICACY FOR PROPHYLAXIS OF BACTERIAL-INFECTIONS AND REDUCTION OF HOSPITALIZATIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILDREN, The Pediatric infectious disease journal, 13(6), 1994, pp. 477-484
TUBERCULOSIS IN HUMAN IMMUNODEFICIENCY VIRUS-EXPOSED OR VIRUS-INFECTED UNITED-STATES CHILDREN
Authors: GUTMAN LT MOYE J ZIMMER B TIAN C
Citation: Lt. Gutman et al., TUBERCULOSIS IN HUMAN IMMUNODEFICIENCY VIRUS-EXPOSED OR VIRUS-INFECTED UNITED-STATES CHILDREN, The Pediatric infectious disease journal, 13(11), 1994, pp. 963-968
Risultati: 1-25 | 26-33